Manufacturer: Samarth Life Sciences Pvt Ltd
Salt Composition : Recombinant follicle stimulating hormone(150IU)
Fshsp 150IU Injection is given as an injection under the supervision of a doctor. Your doctor will decide the right time to take the injection, so always follow your doctor's advice. The dose and how often you take it depends on what you are taking it for. You should take this medicine for as long as it is prescribed for you.
The most common side effects of this medicine include allergic reactions, headache, swelling of the breast in males, and acne. If these bother you or appear serious, let your doctor know. There may be ways of reducing or preventing them.
Before taking this medicine, tell your doctor if you have ever had heart disease, or had an ovarian cyst, or had thyroid gland disorder. Your doctor should also know about all other medicines you are taking as many of these may make this medicine less effective or change the way it works. Tell your doctor if you are pregnant or breastfeeding. You should avoid alcohol or have to follow doctor advice related to diet while taking this medicine.
It works by stimulating the growth of follicles (which contain eggs) in the ovary. This helps in the release of a properly developed egg at the time of ovulation. It is also used in assisted reproductive technology (ART) procedures such as in-vitro fertilization (IVF), which help women to become pregnant.
Recombinant follicle-stimulating hormone (rFSH) is the latest advance in gonadotropin preparations by manufacturing the most purified and antigen-free product through recombinant DNA technology.
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them
Common side effects of Fshsp
Injection site allergic reaction
Headache
Acne
Swelling of breast in male
Abdominal pain
Gastrointestinal discomfort
Ovarian cysts
Rash
Hypersensitivity to Bravelle Injection is a contraindication. In addition, Bravelle Injection should not be used if you have the following conditions:
Abnormal uterine bleeding of undetermined origin
High levels of follicle stimulating hormone indicating primary gonadal failure
Hypersensitivity to this drug
Ovarian cyst or enlargement of undetermined origin, not due to polycystic ovary syndrome
Pregnancy
Sex hormone dependent tumors of the reproductive tract and accessory organ
Tumors of pituitary gland or hypothalamus
Uncontrolled non- gonadal endocrinopathies
Fshsp 150IU Injection is highly unsafe to use during pregnancy. Seek your doctor's advice as studies on pregnant women and animals have shown significant harmful effects to the developing baby.
Caution is advised when consuming alcohol with Fshsp 150IU Injection. Please consult your doctor.
Information regarding the use of Fshsp 150IU Injection during breastfeeding is not available. Please consult your doctor.
Recombinant follicle stimulating hormone is used in the treatment of female infertility and male hypogonadism. It is used in women who have a problem in ovulation or are undergoing fertility treatment like in-vitro fertilization. In men, it helps in the production of sperm cells.
Before using Recombinant follicle stimulating hormone, let your doctor know if you have any Allergic reactions,Blood clots,Kidney problems,Lung problems,Multiple births,Ovarian enlargement,Ovarian hyperstimulation syndrome (OHSS),Pregnancy,Breast-feeding.
Kindly do not self administer.
Store in a refrigerator (2 - 8°C). Do not freeze.
If you miss a dose of Fshsp 150IU Injection, please consult your doctor.
Consult a doctor before taking any medicines.
It may also be used to stimulate sperm formation in men.
The injection is administered under the skin. Follow the recommended dosage and monitoring schedules to minimise the possibility of ovarian hyperstimulation.
Inform your doctor immediately if you have severe pelvic pain, nausea, vomiting, diarrhea, sudden weight gain, trouble breathing, or decreased or no urination during treatment, as these could be symptoms of ovarian hyperstimulation syndrome (OHSS).
Do not use Fshsp 150IU Injection if you are already pregnant or breastfeeding.
Fshsp 150IU Injection stimulates the production of eggs in women undergoing treatment for infertility.
Your doctor may prescribe more than one medicine as part of your suggested pregnancy plan.
Pregnancy following treatment with Fshsp 150IU Injection is more likely to result in a multiple pregnancy (twins or more).
Your doctor or nurse will give you this medicine. Kindly do not self administer.
Q. What is Fshsp 150IU Injection and what it is used for?
Fshsp 150IU Injection contains Follitropin alfa which is a type of Follicle Stimulating Hormone produced naturally by the body. It is used in women who are unable to ovulate. It works by stimulating the growth of follicles (which contain eggs) in the ovary. This helps in the release of a properly developed egg at the time of ovulation. It is also used in assisted reproductive technology (ART) procedures such as in-vitro fertilization (IVF), which help women to become pregnant. It may also be used in adult men who are infertile due to lack of certain hormones and inability to produce enough sperm cells.
Q. How and in what dose should I take Fshsp 150IU Injection?
Fshsp 150IU Injection is an injection given subcutaneously (just under the skin). The dose and treatment duration depend on the ovarian response of the patient.
Q. What if I miss a dose of Fshsp 150IU Injection?
Ideally, you should try not to miss a dose of Fshsp 150IU Injection. However, please talk to your doctor as soon as you remember that you have missed a dose.
Q. What are the side effects of using Fshsp 150IU Injection?
The most common side effect is a local site reaction at the injection site (pain, redness, swelling, and irritation). The other common side effects are a headache, ovarian cysts, abdominal pain or cramping, nausea, vomiting, diarrhea and bloating. If any of these side effects bother you, please consult with your doctor. In addition, this medicine may increase the likelihood of conditions like ovarian hyperstimulation syndrome (OHSS), multiple pregnancy or miscarriage.
